The global Hereditary Angioedema Therapeutic market was valued at US$ 2088.6 million in 2023 and is anticipated to reach US$ 3050 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.

Hereditary Angioedema Therapeutic Market

Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Therapeutic.

Report Scope

The Hereditary Angioedema Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hereditary Angioedema Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hereditary Angioedema Therapeutic Market Report

Report Metric	Details
Report Name	Hereditary Angioedema Therapeutic Market
Accounted market size in 2023	US$ 2088.6 million
Forecasted market size in 2030	US$ 3050 million
CAGR	5.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Intravenous Subcutaneous Oral
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioCryst Pharma, Ionis Pharma, Pharming Group, CSL Limited, Shire, Attune Pharma, Adverum Biotechnologies, KalVista Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hereditary Angioedema Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hereditary Angioedema Therapeutic Market growing?

Ans: The Hereditary Angioedema Therapeutic Market witnessing a CAGR of 5.1% during the forecast period 2024-2030.

What is the Hereditary Angioedema Therapeutic Market size in 2030?

Ans: The Hereditary Angioedema Therapeutic Market size in 2030 will be US$ 3050 million.

Who are the main players in the Hereditary Angioedema Therapeutic Market report?

Ans: The main players in the Hereditary Angioedema Therapeutic Market are BioCryst Pharma, Ionis Pharma, Pharming Group, CSL Limited, Shire, Attune Pharma, Adverum Biotechnologies, KalVista Pharma

What are the Application segmentation covered in the Hereditary Angioedema Therapeutic Market report?

Ans: The Applications covered in the Hereditary Angioedema Therapeutic Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Hereditary Angioedema Therapeutic Market report?

Ans: The Types covered in the Hereditary Angioedema Therapeutic Market report are Intravenous, Subcutaneous, Oral

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Intravenous

1.2.3 Subcutaneous

1.2.4 Oral

1.3 Market by Application

1.3.1 Global Hereditary Angioedema Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hereditary Angioedema Therapeutic Market Perspective (2019-2030)

2.2 Hereditary Angioedema Therapeutic Growth Trends by Region

2.2.1 Global Hereditary Angioedema Therapeutic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hereditary Angioedema Therapeutic Historic Market Size by Region (2019-2024)

2.2.3 Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2025-2030)

2.3 Hereditary Angioedema Therapeutic Market Dynamics

2.3.1 Hereditary Angioedema Therapeutic Industry Trends

2.3.2 Hereditary Angioedema Therapeutic Market Drivers

2.3.3 Hereditary Angioedema Therapeutic Market Challenges

2.3.4 Hereditary Angioedema Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue

3.1.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue (2019-2024)

3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2019-2024)

3.2 Global Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hereditary Angioedema Therapeutic Revenue

3.4 Global Hereditary Angioedema Therapeutic Market Concentration Ratio

3.4.1 Global Hereditary Angioedema Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hereditary Angioedema Therapeutic Revenue in 2023

3.5 Hereditary Angioedema Therapeutic Key Players Head office and Area Served

3.6 Key Players Hereditary Angioedema Therapeutic Product Solution and Service

3.7 Date of Enter into Hereditary Angioedema Therapeutic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Hereditary Angioedema Therapeutic Breakdown Data by Type

4.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2019-2024)

4.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2025-2030)

5 Hereditary Angioedema Therapeutic Breakdown Data by Application

5.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2019-2024)

5.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hereditary Angioedema Therapeutic Market Size (2019-2030)

6.2 North America Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)

6.4 North America Hereditary Angioedema Therapeutic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hereditary Angioedema Therapeutic Market Size (2019-2030)

7.2 Europe Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)

7.4 Europe Hereditary Angioedema Therapeutic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2019-2030)

8.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2019-2024)

8.4 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hereditary Angioedema Therapeutic Market Size (2019-2030)

9.2 Latin America Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)

9.4 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2019-2030)

10.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2019-2024)

10.4 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioCryst Pharma

11.1.1 BioCryst Pharma Company Detail

11.1.2 BioCryst Pharma Business Overview

11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Introduction

11.1.4 BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.1.5 BioCryst Pharma Recent Development

11.2 Ionis Pharma

11.2.1 Ionis Pharma Company Detail

11.2.2 Ionis Pharma Business Overview

11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Introduction

11.2.4 Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.2.5 Ionis Pharma Recent Development

11.3 Pharming Group

11.3.1 Pharming Group Company Detail

11.3.2 Pharming Group Business Overview

11.3.3 Pharming Group Hereditary Angioedema Therapeutic Introduction

11.3.4 Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.3.5 Pharming Group Recent Development

11.4 CSL Limited

11.4.1 CSL Limited Company Detail

11.4.2 CSL Limited Business Overview

11.4.3 CSL Limited Hereditary Angioedema Therapeutic Introduction

11.4.4 CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.4.5 CSL Limited Recent Development

11.5 Shire

11.5.1 Shire Company Detail

11.5.2 Shire Business Overview

11.5.3 Shire Hereditary Angioedema Therapeutic Introduction

11.5.4 Shire Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.5.5 Shire Recent Development

11.6 Attune Pharma

11.6.1 Attune Pharma Company Detail

11.6.2 Attune Pharma Business Overview

11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Introduction

11.6.4 Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.6.5 Attune Pharma Recent Development

11.7 Adverum Biotechnologies

11.7.1 Adverum Biotechnologies Company Detail

11.7.2 Adverum Biotechnologies Business Overview

11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Introduction

11.7.4 Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.7.5 Adverum Biotechnologies Recent Development

11.8 KalVista Pharma

11.8.1 KalVista Pharma Company Detail

11.8.2 KalVista Pharma Business Overview

11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Introduction

11.8.4 KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024)

11.8.5 KalVista Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Adverum Biotechnologies

KalVista Pharma

List of Tables

Table 1. Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Intravenous

Table 3. Key Players of Subcutaneous

Table 4. Key Players of Oral

Table 5. Global Hereditary Angioedema Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Hereditary Angioedema Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Hereditary Angioedema Therapeutic Market Share by Region (2019-2024)

Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Hereditary Angioedema Therapeutic Market Share by Region (2025-2030)

Table 11. Hereditary Angioedema Therapeutic Market Trends

Table 12. Hereditary Angioedema Therapeutic Market Drivers

Table 13. Hereditary Angioedema Therapeutic Market Challenges

Table 14. Hereditary Angioedema Therapeutic Market Restraints

Table 15. Global Hereditary Angioedema Therapeutic Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Hereditary Angioedema Therapeutic Market Share by Players (2019-2024)

Table 17. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2023)

Table 18. Ranking of Global Top Hereditary Angioedema Therapeutic Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Hereditary Angioedema Therapeutic Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Hereditary Angioedema Therapeutic Product Solution and Service

Table 22. Date of Enter into Hereditary Angioedema Therapeutic Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Hereditary Angioedema Therapeutic Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2019-2024)

Table 26. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2025-2030)

Table 28. Global Hereditary Angioedema Therapeutic Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2019-2024)

Table 30. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2025-2030)

Table 32. North America Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Hereditary Angioedema Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Hereditary Angioedema Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Hereditary Angioedema Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 47. BioCryst Pharma Company Detail

Table 48. BioCryst Pharma Business Overview

Table 49. BioCryst Pharma Hereditary Angioedema Therapeutic Product

Table 50. BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 51. BioCryst Pharma Recent Development

Table 52. Ionis Pharma Company Detail

Table 53. Ionis Pharma Business Overview

Table 54. Ionis Pharma Hereditary Angioedema Therapeutic Product

Table 55. Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 56. Ionis Pharma Recent Development

Table 57. Pharming Group Company Detail

Table 58. Pharming Group Business Overview

Table 59. Pharming Group Hereditary Angioedema Therapeutic Product

Table 60. Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 61. Pharming Group Recent Development

Table 62. CSL Limited Company Detail

Table 63. CSL Limited Business Overview

Table 64. CSL Limited Hereditary Angioedema Therapeutic Product

Table 65. CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 66. CSL Limited Recent Development

Table 67. Shire Company Detail

Table 68. Shire Business Overview

Table 69. Shire Hereditary Angioedema Therapeutic Product

Table 70. Shire Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 71. Shire Recent Development

Table 72. Attune Pharma Company Detail

Table 73. Attune Pharma Business Overview

Table 74. Attune Pharma Hereditary Angioedema Therapeutic Product

Table 75. Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 76. Attune Pharma Recent Development

Table 77. Adverum Biotechnologies Company Detail

Table 78. Adverum Biotechnologies Business Overview

Table 79. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product

Table 80. Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 81. Adverum Biotechnologies Recent Development

Table 82. KalVista Pharma Company Detail

Table 83. KalVista Pharma Business Overview

Table 84. KalVista Pharma Hereditary Angioedema Therapeutic Product

Table 85. KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2019-2024) & (US$ Million)

Table 86. KalVista Pharma Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hereditary Angioedema Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Hereditary Angioedema Therapeutic Market Share by Type: 2023 VS 2030

Figure 3. Intravenous Features

Figure 4. Subcutaneous Features

Figure 5. Oral Features

Figure 6. Global Hereditary Angioedema Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Hereditary Angioedema Therapeutic Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Hereditary Angioedema Therapeutic Report Years Considered

Figure 12. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Hereditary Angioedema Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Hereditary Angioedema Therapeutic Market Share by Region: 2023 VS 2030

Figure 15. Global Hereditary Angioedema Therapeutic Market Share by Players in 2023

Figure 16. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2023

Figure 18. North America Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Hereditary Angioedema Therapeutic Market Share by Country (2019-2030)

Figure 20. United States Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Hereditary Angioedema Therapeutic Market Share by Country (2019-2030)

Figure 24. Germany Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2019-2030)

Figure 32. China Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2019-2030)

Figure 40. Mexico Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2019-2030)

Figure 44. Turkey Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Hereditary Angioedema Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. BioCryst Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 47. Ionis Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 48. Pharming Group Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 49. CSL Limited Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 50. Shire Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 51. Attune Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 52. Adverum Biotechnologies Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 53. KalVista Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions